BioSpace News Archive

Xalud Therapeutics, a clinical-stage biotechnology company developing novel non-viral gene therapies to treat pathologic inflammation through immune modulation, today announced relationships with additional independent strategic advisors.

Nascent Biotech, Inc., a biotechnology company pioneering innovative medicines to overcome difficult-to-treat cancers and viral infections, and its collaboration partner, Manhattan BioSolutions, are pleased to announce promising new preliminary preclinical results for the COVID-19 vaccine candidate now progressing under joint development by the Partners.

Immix Biopharma, Inc. today announced that accounting and financial expert Helen C. Adams , CFA has joined the Company’s Board of Directors.

Guardant Health, Inc., a leading precision oncology company, announced it will report financial results for the second quarter 2021 after market close on Thursday, August 5, 2021.

Adamis Pharmaceuticals Corporation urged its valued stockholders to vote to reelect all five members of the Company’s Board of Directors at the upcoming Annual Meeting of Stockholders on July 16, 2021.

AdaptHealth Corp., a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced that it will release its financial results for the second quarter ended June 30, 2021 before the opening of the financial markets on Thursday, August 5, 2021.

Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced its participation in a virtual fireside chat at the William Blair Biotech Focus Conference 2021. Date: Thursday, July 15, 2021 Time: 10 am – 10:45 am Eastern Time

Neovasc Team Grows with Addition of Industry Veterans Lisa Becker as VP, Regulatory Affairs, Global Angina Therapies and Sarah Gallagher as VP of Clinical Affairs.

Ambry Genetics Corporation (Ambry), a Konica Minolta Precision Medicine (KMPM) company and leader in clinical diagnostic testing, has been the leading organization in contributions to The Gene Curation Coalition (GenCC) Database since its launch in December 2020.

Chemistree Technology Inc. (CSE: CHM) (CSE: CHM.WT) (OTCQB: CHMJF) (the “Company” or “Chemistree”) is pleased to confirm that investee company ImmunoFlex Therapeutics Inc. (“ImmunoFlex"™), today announced that it has completed and analyzed its clinical trial of 21 patients, aged 60 to 70 years.